Background: This document provides evidence-based clinical practice guidelines on the
management of adult patients with community-acquired pneumonia. Methods: A …

Community-acquired pneumonia is not usually considered a high-priority problem by the
public, although it is responsible for substantial mortality, with a third of patients dying within …

Bacterial Pneumonia in Older Adults - Infectious Disease Clinics Skip to Main Content
Advertisement Infectious Disease Clinics Log in Register Log in Subscribe Claim Skip menu …

Community-acquired pneumonia is a leading cause of death. Risk factors include older age
and medical comorbidities. Diagnosis is suggested by a history of cough, dyspnea, pleuritic …

Background Addition of macrolide antibiotics to β-lactam antibiotics for the treatment of
patients in hospital with community-acquired pneumonia is based on results from …

Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality both in
the USA and globally. As the burden of CAP continues to increase due to several factors, the …

Introduction Guidelines recommend respiratory fluoroquinolone monotherapy or β-lactam
plus macrolide combination therapy as first-line options for hospitalized adults with mild to …

Abstract The WHO Model List of Essential Medicines (EML) prioritizes medicines that have
significant global public health value. The EML can also deliver important messages on …

Community-acquired pneumonia is common and important infectious disease in adults. This
work represents an update to 2009 treatment guideline for community-acquired pneumonia …

Objectives This meta-analysis examined the effect of macrolides on resolution of community-
acquired pneumonia (CAP) and interpretation of clinical benefit according to microbiology; …